Tony Serafini-Lamanna
CIK 1812602 · Executive VP-Diagnostics · last filed 2023-01-31
Tony Serafini-Lamanna is an Executive VP-Diagnostics who has filed 8 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for VIVO, was dated Jan 31, 2023. Current disclosed insider exposure totals $206.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$206.7K
1
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIVO | Executive VP-Diagnostics | 43,338 | $4.77 | $206.7K | $0 | 8 | 2023-01-31 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-31 | VIVO | Mixed | −35,393 | $0 | EDGAR |
| 2022-11-17 | VIVO | Tax (F) | −3,666 | -$116.7K | EDGAR |
| 2022-11-08 | VIVO | Tax (F) | −788 | -$25.2K | EDGAR |
| 2022-10-05 | VIVO | Tax (F) | −357 | -$11.5K | EDGAR |
| 2021-12-16 | VIVO | Tax (F) | −2,232 | -$45.0K | EDGAR |
| 2021-11-16 | VIVO | Mixed | — | $0 | EDGAR |
| 2021-11-08 | VIVO | Grant (A) | +10,593 | $0 | EDGAR |
| 2020-11-09 | VIVO | Grant (A) | +10,823 | $0 | EDGAR |